{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03193528",
            "orgStudyIdInfo": {
                "id": "Rosser-2015-7"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01CA198887",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01CA198887"
                }
            ],
            "organization": {
                "fullName": "Cedars-Sinai Medical Center",
                "class": "OTHER"
            },
            "briefTitle": "A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer",
            "officialTitle": "A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-novel-multiplex-elisa-assay-for-evaluating-patients-with-gross-hematuria-for-bladder-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-12-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2017-06-17",
            "studyFirstSubmitQcDate": "2017-06-17",
            "studyFirstPostDateStruct": {
                "date": "2017-06-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Charles Rosser",
                "investigatorTitle": "Professor",
                "investigatorAffiliation": "Cedars-Sinai Medical Center"
            },
            "leadSponsor": {
                "name": "Cedars-Sinai Medical Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Fred Hutchinson Cancer Center",
                    "class": "OTHER"
                },
                {
                    "name": "University of Texas",
                    "class": "OTHER"
                },
                {
                    "name": "Nara Medical University",
                    "class": "OTHER"
                },
                {
                    "name": "University of California, Los Angeles",
                    "class": "OTHER"
                },
                {
                    "name": "Nonagen Bioscience Corporation",
                    "class": "INDUSTRY"
                },
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                },
                {
                    "name": "University of Rochester",
                    "class": "OTHER"
                },
                {
                    "name": "Nara Prefecture Seiwa Medical Center",
                    "class": "UNKNOWN"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with gross hematuria.",
            "detailedDescription": "Hematuria is the most common presentation of BCa with 22% of patients with gross hematuria harboring BCa. VUC is the most widely used urine-based assay for detecting BCa; however, it fails to detect approximately 50% of low-grade or early stage BCa when it is most curable.\n\nBecause of this severe limitation, patients with hematuria (microscopic or gross) will undergo an invasive examination of the urinary bladder, where a miniature camera is inserted into the bladder. We propose to improve upon the non-invasive detection of BCa by further validating a multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples of patients with gross hematuria."
        },
        "conditionsModule": {
            "conditions": [
                "Bladder Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Urine collection (minimal 50 mL) and cystoscopy (+ biopsy w/in 4 weeks, if abnormal noted)"
            },
            "enrollmentInfo": {
                "count": 450,
                "type": "ESTIMATED"
            }
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To examine the sensitivity and specificity of the multiplex ELISA assay directed at a BCa-associated diagnostic signature in voided urine samples to reference standard of cystoscopy in a cohort of 450 participants presenting with gross hematuria.",
                    "timeFrame": "1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "To compare the sensitivity and specificity of the multiplex ELISA assay to VUC and NMP22\u00ae BladderChek to reference standard of cystoscopy in this cohort.",
                    "timeFrame": "1 year"
                },
                {
                    "measure": "To develop a BCa risk calculator from this cohort using cutting edge machine learning techniques (e.g., random forest) incorporating biomarker data and clinical data.",
                    "timeFrame": "1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18 years or older\n* Have documented or reported gross hematuria within 3 month of study enrollment\n* Willing and able to give written informed consent\n\nExclusion Criteria (patients must not):\n\n* Have history of BCa\n* History of previous cancer (excluding basal and squamous cell skin cancer) within the past 3 years\n* Have a known active urinary tract infection or urinary retention\n* Have active stone disease (renal or bladder) or renal insufficiency (creatinine \\>2.0 mg/dL) Serum creatinine value can be up to 60 days before consent, otherwise repeat\n* Have ureteral stents, nephrostomy tubes or bowel interposition\n* Have recent genitourinary instrumentation (within 10 days prior to signing consent)\n* Be unable or unwilling to complete the hematuria evaluation (i.e., cystoscopy and upper tract imaging)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Adults, age 18 and older who have documented gross hematuria within the past 3 months who are referred for cystoscopy and are willing to participate",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Charles Rosser, MD",
                    "role": "CONTACT",
                    "phone": "310-423-5609",
                    "email": "charles.rosser@cshs.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Charles Rosser, MD",
                    "affiliation": "Nonagen Bioscience Corporation",
                    "role": "STUDY_DIRECTOR"
                },
                {
                    "name": "Hideki Furuya, MD",
                    "affiliation": "Cedars-Sinai Medical Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cedars-Sinai Medical Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90048",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amy Oppenheim",
                            "role": "CONTACT",
                            "phone": "310-423-3713",
                            "email": "Amy.Oppenheim@cshs.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of California Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Arnold Chin, MD, PhD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "University of Rochester Medical Center",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "New York",
                    "zip": "14627",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edward Messing, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.15478,
                        "lon": -77.61556
                    }
                },
                {
                    "facility": "UT Southwestern Medical Center at Dallas",
                    "status": "RECRUITING",
                    "city": "Dallas",
                    "state": "Texas",
                    "zip": "75390",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yair Lotan",
                            "role": "CONTACT",
                            "phone": "214-648-0389",
                            "email": "yair.lotan@utsouthwestern.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.78306,
                        "lon": -96.80667
                    }
                },
                {
                    "facility": "Department of Urology, Nara Medical University",
                    "status": "RECRUITING",
                    "city": "Nara",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Takuto Shimizu, MD",
                            "role": "CONTACT",
                            "phone": "+81-744-22-3051"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.68505,
                        "lon": 135.80485
                    }
                },
                {
                    "facility": "Nara Precfecture Seiwa Medical Center",
                    "status": "RECRUITING",
                    "city": "Nara",
                    "country": "Japan",
                    "contacts": [
                        {
                            "name": "Satoshi Anai, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.68505,
                        "lon": 135.80485
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001749",
                    "term": "Urinary Bladder Neoplasms"
                },
                {
                    "id": "D000006417",
                    "term": "Hematuria"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000001745",
                    "term": "Urinary Bladder Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000014555",
                    "term": "Urination Disorders"
                },
                {
                    "id": "D000006470",
                    "term": "Hemorrhage"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5030",
                    "name": "Urinary Bladder Neoplasms",
                    "asFound": "Bladder Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9504",
                    "name": "Hematuria",
                    "asFound": "Hematuria",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M5026",
                    "name": "Urinary Bladder Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17305",
                    "name": "Urination Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9556",
                    "name": "Hemorrhage",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}